Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat

计划入组 80 人 · 首次发布于 2016 年 11 月 25 日

IL-1β and S1P Levels After Periodontal Therapy: A Split-Mouth Study

计划入组 17 人 · 首次发布于 2025 年 4 月 16 日

S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain

计划入组 21 人 · 首次发布于 2016 年 12 月 28 日

S1P-104

S1P 1/S1P 5 selective agonists (Receptos)

S1P (York Pharma)

Ventyx Biosciences

United States

Grupo Unamis Scp

Mexico

SSP Co., Ltd.

Japan

Ozanimod Shows Sustained Reduction in Brain Atrophy in Relapsing Multiple Sclerosis

Priothera Secures €1.7 Million Government Funding to Enhance CAR-T Cell Therapy with Novel S1P Receptor Modulator

BMS Seeks FDA Approval for Zeposia in Ulcerative Colitis with May Decision Date